Tag Archives: repressive tolerance

It feels like they win when they lose – hegemonic accommodation and institutional entrepreneurs

I re-read

Levy, D. and Scully, M. 2007. The Institutional Entrepreneur as Modern Prince: The Strategic Face of Power in Contested Fields. Organization Studies, 28(07): 971–991.

while slogging around Alex Park with my backpack full of books and weights this morning.  I had forgotten just how damn good it is, and how damn useful it will be For The Thesis.

I could quote for ages – especially on ‘The Modern Prince’ , but a) time b) your attention c) copyright. So for now, this – the notion of ‘hegemonic accommodation’ – a cousin of Marcuse’s ‘repressive tolerance’.  There’s useful stuff in this for me thinking about the big voluntary scheme that the Howard Government used as a fig-leaf (one it inherited from Keating, and duly expanded), also known as ‘the Greenhouse Challenge.’  The analogy with the Access Campaign is fairly weak – the NGOs in the Australian case were aiming for a carbon tax, and got rolled, not co-opted…

The interaction between the strategies of institutional entrepreneurs and defenders frequently gives rise to a characteristic pattern of limited accommodation while preserving, or even reinforcing, the essentials of field power structures. Pragmatic entrepreneurs, seeking to legitimize their claims, frequently use insider language and practices to drive change (Meyerson and Scully 1995) and ‘embed calls for change within accepted models’ (Clemens and Cook 1999: 459).
(Levy and Scully, 2007: 984)

In agreeing to establish a forum for consultation, industry not only enhanced its legitimacy but also gained financially from the marketing value of this information and from expanded insurance coverage.
(Levy and Scully, 2007: 985)

Though the Access Campaign is generally credited with having ‘won’ the struggle to allow low-cost generic drugs in developing countries, this institutional settlement was also a hegemonic accommodation.
(Levy and Scully, 2007: 985)

Indeed, pharmaceutical companies quickly moved to claim credit for expanded drug access and embraced the discourse of corporate social responsibility. The power of even the most skillful institutional entrepreneurs is constrained by the nesting of issue-level fields within wider, well-entrenched institutions. Institutional entrepreneurship has been characterized using salient episodes and discontinuities but is an ongoing, situated process.
(Levy and Scully, 2007: 985)

Advertisements